This protocol is judged by an institutional evaluation board, an unbiased group that evaluations any scientific trials involving human beings. If a research involves a Timetable I drug, after the board approves the protocol as ethical, the researchers really need to make an application for an investigational new drug (IND) range through the FDA.“